Healthcare companies are interesting because they are not highly correlated with macroeconomic factors.
*Stock prices used were the afternoon prices of Feb. 15, 2025. The video was published on Feb. 17, 2025.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Stocks Mentioned
AstraZeneca Plc
AZN
$67.88
(-0.19%)
$0.13
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
3 No-Brainer Growth Stocks to Buy for Less Than $100
Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
3 Magnificent Growth Stocks to Buy Right Now
Why AstraZeneca Topped the Market on Thursday
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.